Works matching AU Tang, Ling-Long


Results: 81
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    Tissue-resident microbiota signature in nasopharyngeal carcinoma.

    Published in:
    Microbiome, 2025, v. 13, n. 1, p. 1, doi. 10.1186/s40168-025-02114-w
    By:
    • Tan, Xi-Rong;
    • Qiao, Han;
    • Li, Ying-Qing;
    • Jiang, Wei;
    • Huang, Sheng-Yan;
    • Gong, Sha;
    • Li, Wen-Fei;
    • Tang, Ling-Long;
    • Zhou, Guan-Qun;
    • Liang, Ye-Lin;
    • Li, Hui;
    • He, Qing-Mei;
    • Bai, Jie-Wen;
    • Ye, Ming-Liang;
    • Wang, Jing-Yun;
    • Huang, Sai-Wei;
    • Li, Jun-Yan;
    • Gan, Chun-Qiao;
    • Li, Ying-Qin;
    • Zhao, Yin
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26

    MRI-detected skull-base invasion.

    Published in:
    Strahlentherapie und Onkologie, 2014, v. 190, n. 10, p. 905, doi. 10.1007/s00066-014-0656-7
    By:
    • Cheng, Yi-Kan;
    • Liu, Li-Zhi;
    • Jiang, Ning;
    • Yue, Dan;
    • Tang, Ling-Long;
    • Zhang, Fan;
    • Lin, Li;
    • Liu, Xu;
    • Chen, Lei;
    • Ma, Jun
    Publication type:
    Article
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37

    Adjuvant PD-1 Blockade With Camrelizumab for Nasopharyngeal Carcinoma: The DIPPER Randomized Clinical Trial.

    Published in:
    JAMA: Journal of the American Medical Association, 2025, v. 333, n. 18, p. 1589, doi. 10.1001/jama.2025.1132
    By:
    • Liang, Ye-Lin;
    • Liu, Xu;
    • Shen, Liang-Fang;
    • Hu, Guang-Yuan;
    • Zou, Guo-Rong;
    • Zhang, Ning;
    • Chen, Chuan-Ben;
    • Chen, Xiao-Zhong;
    • Zhu, Xiao-Dong;
    • Yuan, Ya-Wei;
    • Yang, Kun-Yu;
    • Jin, Feng;
    • Hu, Wei-Han;
    • Xie, Fang-Yun;
    • Huang, Ying;
    • Han, Fei;
    • Tang, Ling-Long;
    • Mao, Yan-Ping;
    • Lu, Li-Xia;
    • Sun, Rui
    Publication type:
    Article
    38
    39
    40

    Progress report of a randomized trial comparing long-term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions of China

    Published in:
    Cancer (0008543X), 2013, v. 119, n. 12, p. 2230, doi. 10.1002/cncr.28049
    By:
    • Chen, Yong;
    • Sun, Ying;
    • Liang, Shao‐Bo;
    • Zong, Jing‐Feng;
    • Li, Wen‐Fei;
    • Chen, Mo;
    • Chen, Lei;
    • Mao, Yan‐Ping;
    • Tang, Ling‐Long;
    • Guo, Ying;
    • Lin, Ai‐Hua;
    • Liu, Meng‐Zhong;
    • Ma, Jun
    Publication type:
    Article
    41
    42
    43
    44
    45

    Reduced‐volume radiotherapy versus conventional‐volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open‐label, noninferiority, multicenter, randomized phase 3 trial.

    Published in:
    CA: A Cancer Journal for Clinicians, 2025, v. 75, n. 3, p. 203, doi. 10.3322/caac.21881
    By:
    • Tang, Ling‐Long;
    • Chen, Lin;
    • Xu, Gui‐Qiong;
    • Zhang, Ning;
    • Huang, Cheng‐Long;
    • Li, Wen‐Fei;
    • Mao, Yan‐Ping;
    • Zhou, Guan‐Qun;
    • Lei, Feng;
    • Chen, Lu‐Si;
    • Huang, Shao Hui;
    • Chen, Lei;
    • Chen, Yu‐Pei;
    • Zhang, Yuan;
    • Liu, Xu;
    • Xu, Cheng;
    • Zhao, Yin;
    • Li, Ji‐Bin;
    • Liu, Na;
    • Xie, Fang‐Yun
    Publication type:
    Article
    46
    47
    48
    49
    50